Back

Differential prognostic value of platelet reactivity and CYP2C19 phenotype in high bleeding risk patients undergoing PCI: insights from the PTRG-DES Registry

30 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Targeting platelets post-percutaneous coronary intervention Antiplatelet Drugs ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jung-Joon Cha

Korea University Anam Hospital, Seoul (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Short-term DAPT followed by P2Y12 monotherapy versus standard-term DAPT after PCI for ACS: an updated systematic review and meta-analysis of randomised controlled trials
Associate Professor M. Monaghan (Enniskillen, GB)
Abstract Slides Video
Presentation thumbnail
Impact of age on comparative outcomes of abbreviated versus standard antiplatelet therapy in patients at high bleeding risk: a pre-specified analysis from the MASTER-DAPT trial
Doctor A. Landi (Lugano, CH)
Abstract Slides Video
Presentation thumbnail
Ticagrelor-based dual antiplatelet therapy versus aspirin monotherapy after CABG: a systematic review and meta-analysis of randomized controlled trials
Mr R. Goes (Asa Sul Brasilia, BR)
Abstract Slides Video
Presentation thumbnail
Clopidogrel versus aspirin for secondary prevention of coronary artery disease stratified by age: an individual patient data meta-analysis of 28,982 patients from 7 randomized trials
Doctor D. Giacoppo (Catania, IT)
Abstract Slides
Presentation thumbnail
Potent P2Y12 inhibitor monotherapy without aspirin early after percutaneous coronary intervention: the NEO-MINDSET Platelet Function Substudy
Doctor P. Guimaraes (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Targeting platelets post-percutaneous coronary intervention

The Event

Event poster

ESC Congress 2026

30 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
iRight4Me: individualisation of P2Y12 inihibitors in the realworld practice - an interim report
1 September 2024
thumbnail
Congress Presentation
Early bleeding risk prediction with the PRECISE-HBR score in PCI patients treated with cangrelor: the ICARUS registry
31 August 2026
thumbnail
Congress Presentation
Intensity of dual antiplatelet therapy based on thrombotic and bleeding risks after coronary stenting
26 August 2023
thumbnail
Congress Presentation
Differential prognostic significance of platelet reactivity based on ischemic risk after percutaneous coronary intervention
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources